Table 1.
Characteristics | Count (%) |
---|---|
Gender | |
Female | 245 (71.4%) |
Male | 98 (28.6%) |
| |
Disease manifestation | |
Isolated thyroid nodule | 141 (44.31%) |
Thyroid nodule + cervical LAP | 64 (20.3%) |
Isolated cervical LAP | 102 (32.3%) |
Central cervical LAP | 1 (0.98%) |
Unilateral cervical LAP | 39 (38.235%) |
Bilateral cervical LAP | 52 (50.98%) |
Central + (unilateral or bilateral) cervical LAP | 4 (3.922%) |
Submandibular LAP | 6 (5.882%) |
Distant lymph node metastasis | 9 (2.8%) |
Supraclavicular LAP | 3 (0.9%) |
Subclavicular LAP | 2 (0.6%) |
Mediastinal LAP | 4 (1.3%) |
Skin metastasis | 1 (0.316%) |
| |
Cervical lymphadenopathy | |
NA | 120 (35.0%) |
No cervical LAP | 31 (9.0%) |
Paratracheal LAP | 5 (1.5%) |
Pretracheal or central LAP | 25 (7.3%) |
Unilateral, bilateral, or contralateral cervical LAP | 152 (44.3%) |
Retropharyngeal or superior mediastinal LAP | 4 (1.2%) |
Distant lymph node metastasis | 6 (1.7%) |